Blueprint for a Catalan Apheresis Database Initiative: The Catalan Apheresis Therapeutics Network and Its Role in Supporting Health Administration Planning.

IF 2.2 3区医学 Q3 HEMATOLOGY

Blood Purification Pub Date : 2025-03-20 DOI:10.1159/000545202

Joan Cid, Eva Rodríguez, Sandra Ortega, Anna M Garcia, Jordi Comas, Paola Charry, Miquel Lozano, Rosa Ramos

{"title":"Blueprint for a Catalan Apheresis Database Initiative: The Catalan Apheresis Therapeutics Network and Its Role in Supporting Health Administration Planning.","authors":"Joan Cid, Eva Rodríguez, Sandra Ortega, Anna M Garcia, Jordi Comas, Paola Charry, Miquel Lozano, Rosa Ramos","doi":"10.1159/000545202","DOIUrl":null,"url":null,"abstract":"<p><p>The Therapeutic Apheresis Database (AfTerCat) was developed to consolidate and standardize data collection for therapeutic apheresis procedures public and private institutions in Catalonia. It covers procedures performed between 2019 and 2023 in 21 apheresis units, with over 26,000 entries, including plasma treatments, cell therapies, and cytapheresis. Variations in workload across public and private institutions were noted, which affecting resource needs and operational costs. By streamlining manual data collection and planning future automation, the AfTerCat registry aims to provide crucial insights for healthcare administrators in optimizing resource allocation, managing procedure costs, and supporting evidence-based policy decisions. The registry's integration into the Organització Catalana de Trasplantaments' (OCATT) digital transformation initiative highlights its potential to impact health policy through improving data centralization and real-time analysis. This project serves as a foundational step toward efficient health system planning and cost management in the growing field of therapeutic apheresis.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"1-11"},"PeriodicalIF":2.2000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545202","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

The Therapeutic Apheresis Database (AfTerCat) was developed to consolidate and standardize data collection for therapeutic apheresis procedures public and private institutions in Catalonia. It covers procedures performed between 2019 and 2023 in 21 apheresis units, with over 26,000 entries, including plasma treatments, cell therapies, and cytapheresis. Variations in workload across public and private institutions were noted, which affecting resource needs and operational costs. By streamlining manual data collection and planning future automation, the AfTerCat registry aims to provide crucial insights for healthcare administrators in optimizing resource allocation, managing procedure costs, and supporting evidence-based policy decisions. The registry's integration into the Organització Catalana de Trasplantaments' (OCATT) digital transformation initiative highlights its potential to impact health policy through improving data centralization and real-time analysis. This project serves as a foundational step toward efficient health system planning and cost management in the growing field of therapeutic apheresis.

查看原文本刊更多论文

加泰罗尼亚血液净化数据库倡议蓝图：加泰罗尼亚血液净化治疗网络及其在支持卫生行政规划中的作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Blood Purification 医学-泌尿学与肾脏学

CiteScore

5.80

自引率

3.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.